Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-008710
Filing Date
2025-03-20
Accepted
2025-03-20 18:12:18
Documents
1
Period of Report
2025-03-18

Document Format Files

Seq Description Document Type Size
1 form4-03202025_100314.html 4  
1 form4-03202025_100314.xml 4 10600
  Complete submission text file 0001415889-25-008710.txt   12102
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVE BEDFORD MA 01730
Business Address
Ticho Barry (Reporting) CIK: 0001780088 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 25758024